This study was designed to investigate whether functional and molecular MRI techniques are sensitive biomarkers for assessment of neuroinflammation and drug efficacy after traumatic brain injury (TBI) in rats. We subjected rats to a controlled cortical impact model and used behavioral tests, histology, and immunofluorescence to assess whether flavonoid pinocembrin provides cerebral protection and improves functional recovery. Most importantly, we used multiple noninvasive structural, functional, and molecular MRI techniques to examine whether the pinocembrin-related neuroprotection and attenuation of neuroinflammation can be detected in vivo. Significant increases in cerebral blood flow (CBF) and amide proton transfer-weighted (APTw) MRI signals were observed in the perilesional areas in untreated TBI rats at 3 days and could be attributed to increased glial response. In addition, increased apparent diffusion coefficient and decreased magnetization transfer ratio signals in untreated TBI rats over time were likely due to edema. Post-treatment with pinocembrin decreased microglial/macrophage activation at 3 days, consistent with the recovery of CBF and APTw MRI signals in regions of secondary injury. These findings suggest that pinocembrin provides cerebral protection for TBI and that multiple MRI signals, CBF and APTw in particular, are sensitive biomarkers for identification and assessment of neuroinflammation and drug efficacy in the TBI model.
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Introduction
Traumatic brain injury (TBI) is a serious public health problem that affects an estimated 1.7 million Americans annually (CDC statistics, 2010) . It is a complex injury that results in primary injury and secondary injury cascades. Variable outcomes of patients after TBI and the multiple definitions of TBI make interpreting results across research studies challenging (Amyot et al., 2015) . Currently, no drug is effective for treatment of TBI, and clinical trials of neuroprotective drugs have not shown clear benefit in reducing or preventing secondary brain damage (McConeghy et al., 2012) . Therefore, it is imperative to develop an effective treatment for TBI.
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